Spearhead Capital Advisors, LLC

SEC CIK: 0001718982
Latest filing: Nov 9, 2022

SEC filings (opens in a new tab)

ALLO holding history

Allogene Therapeutics, Inc. in every 13F filed by Spearhead Capital Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALLO overview All 13F holders of ALLO Full Q3 2022 holdings

Shares (Q4 2021): 0; Sold out in Q4 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2021

Holdings of ALLO by Spearhead Capital Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2021	0	$0	0.0%	−10,652−100.0%	Sold out	Holders
Q3 2021	10,652	$274.0K	<0.1%	−425−3.8%	Reduced	Holders
Q2 2021	11,077	$289.0K	<0.1%	+11,077	New	Holders